A Roundup motion to consolidate (PDF) seeks to organize the litigation in the Southern District of Illinois before Judge Nancy Rosenstengel or David Herndon. A similar motion is pending to consolidate the cases in the US District Court of Hawaii.
The International Agency for Research on Cancer (IARC), the specialized intergovernmental cancer agency of the World Health Organization, declared in March 2015 that glyphosate, the chemical in Roundup, is a “probable carcinogen.”
Roundup is used in 130 countries and is found in rivers and groundwater, according to many studies. Plants absorb glyphosate and it cannot be removed by washing or peeling produce or by milling, baking or brewing grains. It has been found in food, in the urine of agricultural works and even in the urine of urban dwellers who are not in direct contact with glyphosate. Those most at risk are farm workers, landscapers and employees of garden centers and nurseries.
Charles Bridgeman filed a lawsuit July 18 in U.S. District Court for the Southern District of Illinois against Monsanto Company alleging failure to use ordinary care in designing and manufacturing Roundup, failure to accompany their product with proper warnings and failure to conduct adequate testing and post-marketing surveillance to determine the safety of product. It is case number 3:16-cv-00812
According to the complaint, beginning in 1990, Bridgeman regularly used the defendants’ product, Roundup, to control weeds. The suit says in 2011 Bridgeman was diagnosed with non-Hodgkin lymphoma, which he alleges is a direct result from his exposure to the herbicide.
The lawsuit states he suffered serious and dangerous side effects, as well as other severe and permanent injuries, physical pain and mental anguish, incurred medical expenses and diminished enjoyment of life.
He is represented by attorneys Edward A. Wallace and by Corey G. Lorenz of Wexler Wallace LLP in Chicago, and by Yvonne Flaherty of Lockridge Grindal Nauen PLLP in Minneapolis.